# Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.

> **NCT06066762** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 200 (estimated)

## Conditions studied

- Heparin-induced Thrombocytopenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06066762
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06066762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06066762, "Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06066762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*